A detailed history of Wendell David Associates Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Wendell David Associates Inc holds 20,452 shares of ZTS stock, worth $3.94 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
20,452
Previous 21,717 5.82%
Holding current value
$3.94 Million
Previous $3.68 Million 3.51%
% of portfolio
0.36%
Previous 0.37%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$145.54 - $178.83 $184,108 - $226,219
-1,265 Reduced 5.82%
20,452 $3.55 Million
Q1 2024

Apr 22, 2024

SELL
$165.67 - $199.94 $66,268 - $79,976
-400 Reduced 1.81%
21,717 $3.68 Million
Q4 2023

Jan 22, 2024

BUY
$151.44 - $200.09 $15,144 - $20,009
100 Added 0.45%
22,117 $4.37 Million
Q3 2023

Oct 20, 2023

BUY
$167.14 - $192.77 $128,864 - $148,625
771 Added 3.63%
22,017 $3.83 Million
Q2 2023

Jul 20, 2023

BUY
$160.94 - $186.23 $273,758 - $316,777
1,701 Added 8.7%
21,246 $3.66 Million
Q1 2023

Apr 19, 2023

BUY
$145.48 - $175.02 $50,918 - $61,257
350 Added 1.82%
19,545 $3.25 Million
Q4 2022

Jan 17, 2023

SELL
$131.14 - $157.47 $26,883 - $32,281
-205 Reduced 1.06%
19,195 $2.81 Million
Q3 2022

Oct 18, 2022

BUY
$148.29 - $182.55 $3,410 - $4,198
23 Added 0.12%
19,400 $2.88 Million
Q2 2022

Jul 14, 2022

SELL
$155.97 - $200.09 $7,798 - $10,004
-50 Reduced 0.26%
19,377 $3.33 Million
Q1 2022

Apr 22, 2022

BUY
$181.39 - $234.03 $6,348 - $8,191
35 Added 0.18%
19,427 $3.66 Million
Q4 2021

Jan 24, 2022

SELL
$193.69 - $247.03 $590,754 - $753,441
-3,050 Reduced 13.59%
19,392 $4.73 Million
Q3 2021

Oct 19, 2021

BUY
$189.29 - $209.69 $66,251 - $73,391
350 Added 1.58%
22,442 $4.36 Million
Q2 2021

Jul 19, 2021

BUY
$155.9 - $187.99 $44,431 - $53,577
285 Added 1.31%
22,092 $4.12 Million
Q1 2021

Apr 20, 2021

BUY
$144.0 - $169.39 $419,328 - $493,263
2,912 Added 15.41%
21,807 $3.43 Million
Q4 2020

Jan 22, 2021

BUY
$157.07 - $174.35 $9,895 - $10,984
63 Added 0.33%
18,895 $3.13 Million
Q3 2020

Oct 20, 2020

BUY
$137.1 - $165.37 $132,301 - $159,582
965 Added 5.4%
18,832 $3.11 Million
Q2 2020

Jul 17, 2020

BUY
$111.92 - $142.53 $171,797 - $218,783
1,535 Added 9.4%
17,867 $2.45 Million
Q1 2020

Apr 16, 2020

BUY
$92.66 - $144.94 $25,944 - $40,583
280 Added 1.74%
16,332 $1.92 Million
Q4 2019

Jan 17, 2020

BUY
$116.25 - $133.25 $232,500 - $266,500
2,000 Added 14.23%
16,052 $2.12 Million
Q3 2019

Oct 22, 2019

BUY
$112.57 - $128.43 $210,280 - $239,907
1,868 Added 15.33%
14,052 $1.75 Million
Q2 2019

Jul 16, 2019

BUY
$97.98 - $114.28 $138,641 - $161,706
1,415 Added 13.14%
12,184 $1.38 Million
Q1 2019

Apr 11, 2019

BUY
$81.56 - $100.67 $1,549 - $1,912
19 Added 0.18%
10,769 $1.08 Million
Q4 2018

Jan 17, 2019

BUY
$79.28 - $95.27 $7,928 - $9,527
100 Added 0.94%
10,750 $920,000
Q3 2018

Oct 12, 2018

SELL
$83.5 - $93.23 $18,787 - $20,976
-225 Reduced 2.07%
10,650 $975,000
Q1 2018

Apr 11, 2018

BUY
$71.51 - $84.69 $41,118 - $48,696
575 Added 5.58%
10,875 $908,000
Q4 2017

Jan 16, 2018

BUY
$63.24 - $72.8 $50,592 - $58,240
800 Added 8.42%
10,300 $742,000
Q3 2017

Oct 17, 2017

BUY
$59.73 - $65.4 $567,435 - $621,300
9,500
9,500 $606,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $90.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Wendell David Associates Inc Portfolio

Follow Wendell David Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.